Summary
The increasing use of ibuprofen for the treatment of fever in children has caused concern about possible toxic effects. In susceptible adults ibuprofen has caused kidney dysfunction. While it is unlikely that a child with known kidney disease would be given ibuprofen, many children with febrile illnesses are dehydrated. This report presents an analysis of pre- and poststudy observations from 2 clinical trials that compared the antipyretic effects of ibuprofen and paracetamol in 180 otherwise healthy febrile children.
In the first trial, 119 febrile children received a single oral dose of either placebo, paracetamol or one of 2 doses of ibuprofen. In the second trial, 61 children received either paracetamol or one of 3 doses of ibuprofen orally every 6 hours for between 24 and 48 hours. Pre- and poststudy blood chemistries, urine and vital signs were analysed.
Liberal statistical analyses identified few adverse effects and no clinically significant adverse effects. Statistically significant changes were all consistent with poststudy haemodilution (rehydration) except for blood urea nitrogen (BUN). Poststudy BUN concentrations were statistically significantly greater than prestudy values for paracetamol- and ibuprofen-treated patients. However, none of the BUN results were abnormal or clinically important.
Although this study found no clinically significant adverse effects, much larger studies are necessary to establish safety in the general population.
Similar content being viewed by others
References
Atkinson LK, Goodship THJ, Ward MK. Acute renal failure associated with acute pyelonephritis and consumption of nonsteroidal anti-inflammatory drugs. British Medical Journal 292: 97–98, 1986
Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal anti-inflammatory drugs. New England Journal of Medicine 310: 563–572, 1984
Editorial. Ibuprofen vs acetaminophen in children. Medical Letter on Drugs and Therapeutics 31: 109–110, 1989
Fowler PD. Aspirin, paracetamol and non-steroidal anti-inflammatory drugs: a comparative review of side effects. Medical Toxicology 2: 338–366, 1987
Kelley MT, Walson PD, Edge JH, Cox S, Mortensen ME. Pharmacokinetics and pharmacodynamics of ibuprofen isomers and acetaminophen in febrile children. Clinical Pharmacology and Therapeutics 52: 181–189, 1992
Murry MD, Brater DC, Tierney WM, Hui SL, McDonald CJ. Ibuprofen-associated renal impairment in a large general internal medicine practice. American Journal of the Medical Sciences 299: 222–229, 1990
Perry SJ, Streete PJ, Volans GN. Ibuprofen overdose: the first two years of over the counter sales. Human Toxicology 6: 173–178, 1987
Royer GL, Seckman CE, Welshman IR. Safety profile: fifteen years of clinical experience with ibuprofen. American Journal of Medicine 77: 25–34, 1984
Temple AR. Pediatric dosing of acetaminophen. Pediatric Pharmacology 3: 321–327, 1983
Walson PD, Galletta G, Braden NJ, Alexander L. Ibuprofen, acetaminophen, and placebo treatment of febrile children. Clinical Pharmacology and Therapeutics 46: 9–17, 1989
Walson PD, Galletta G, Chomilo F, Braden NJ, Sawyer LA, et al. Comparison of multidose ibuprofen and acetaminophen therapy in febrile children. American Journal of Diseases of Children 146: 626–632, 1992
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kelley, M.T., Walson, P.D., Hayes, J.R. et al. Safety of Paracetamol and Ibuprofen in Febrile Children. Drug Invest 6, 48–56 (1993). https://doi.org/10.1007/BF03259427
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03259427